Boussard & Gavaudan Investment Management LLP Enovis Corp Transaction History

Boussard & Gavaudan Investment Management LLP

$407 Million
Q3 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2022 Nov 09, 2022	SELL	$46.07 - $60.1 $3.06 Million - $3.99 Million	-66,397 Reduced 56.19%	51,775 $2.47 Million
Q2 2022 Aug 10, 2022	BUY	$55.0 - $70.47 $6.5 Million - $8.33 Million	118,172 New	118,172 $6.5 Million

Others Institutions Holding ENOV

# of Institutions

310

Shares Held

60.2M

Call Options Held

1.68M

Put Options Held

693K

T. Rowe Price Investment Management, Inc. Baltimore, MD

6.63M
Shares

$292 Million
0.17% of portfolio
Black Rock Inc. New York, NY

5.43M
Shares

$239 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

5.41M
Shares

$238 Million
0.0% of portfolio
Diamond Hill Capital Management Inc Columbus, OH

3M
Shares

$132 Million
0.54% of portfolio
Dimensional Fund Advisors LP Austin, TX

2.99M
Shares

$131 Million
0.03% of portfolio

View Full List

About Enovis CORP

Ticker ENOV
Exchange NYSE
Sector Industrials
Industry Specialty Industrial Machinery
Shares Outstandng 54,129,500
Market Cap $2.38B
Description
Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat p...

More about ENOV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Boussard & Gavaudan Investment Management LLP, based on Form 13F filings with the SEC.

News

Stay updated on Boussard & Gavaudan Investment Management LLP with notifications on news.

Account